Single base oligodeoxyguanosine upregulates Fas ligand release by nonspecific cytotoxic cells

Developmental and Comparative Immunology

Volumn 28, Issue 6, 2004, Pages 571-579

  Kaur, Harjeet ^a   Jaso Friedmann, Liliana ^b   Evans, Donald L ^b  

^a North Carolina State University   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Annexin V; DNA hypoploidy; Fas receptor; Nonspecific cytotoxic cells; Oligodeoxyguanosine; Programmed cell death; Single base oligos; Soluble Fas ligand

Indexed keywords

ANNEXIN; FAS LIGAND; GUANOSINE DERIVATIVE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; CATFISH; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; LIGAND BINDING; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELEOST; UPREGULATION;

CATFISH; TELEOSTEI;

EID: 1142285362     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2003.09.015     Document Type: Article

References (47)

1. Russell J.H. Activation-induced death of mature T-cells in the regulation of immune responses. Curr Opin Immunol. 7:(3):1995;382-394.
2. Montel A.H., Bochan M.R., Goebel W.S., Bramhi Z. Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line. Cell Immunol. 165:(2):1995;312-317.
3. Oshimi Y., Oda S., Honda Y., Nagata S., Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol. 157:(7):1996;2909-2915.
4. Griffith T., Brunner T., Fletcher S., Green D., Ferguson T. Fas-ligand induced apoptosis as a mechanism of immune privilege. Science. 270:(5239):1995;1189-1192.
5. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R.C. A role for CD95 ligand in preventing graft rejection. Nature. 377:(6550):1995;630- 632.
6. Allison J., Georgiou H.M., Strasser A., Vaux D.L. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration, but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci. 94:(8):1997;3943-3947.
7. Kang S.M., Schneider D.B., Lin Z., Hanahan D., Dichek D.A., Strock P.G., Baekkeskov S. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med. 3:(7):1997;738-743.
8. Kashii Y., Giorda R., Herberman R.B., Whiteside T.L., Vujanovic N.L. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol. 163:(10):1999;5358-5366.
9. Bossi G., Griffiths G.M. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nature Med. 5:(1):1999;90-96.
10. Martinez-Lorenzo M.J., Anel A., Gamen S., Monle N.I., Lasierra P., Larrad L., Pineiro A., Alava M.A., Naval J. Activated human T cells release bioactive Fas Ligand and APO2 ligand in microvesicles. J Immunol. 163:(3):1999;1274-1281.
11. Sieg S., Smith D., Kaplan D. Differential activity of soluble versus cellular Fas ligand: regulation by an accessory molecule. Cellular Immunol. 195:(2):1999;89-95.
12. Shudo K., Kinoshita K., Inamura R., Fan H., Hasumoto K., Tanaka M., Nagata S., Suda T. The membrane-bound but not soluble form of human Fas ligand is responsible for its inflammatory activity. Eur J Immunol. 31:(8):2001;2504-2511.
13. Tanaka M., Suda T., Haze K., Nakamura N., Sato K., Kimura F., Motoyoshi K., Mizuki M., Tagawa S., Ohga S., Hatake K., Drummond A.H., Nagata S. Fas ligand in human serum. Nature Med. 2:(3):1996;317-322.
14. Martinez-Lorenzo M.J., Alava M.A., Anel A., Pineiro A., Naval J. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology. 89:(4):1996;511-517.
15. Monleon I., Martinez-Lorenzo M.J., Monteagudo J., Lasierra P., Taules M., Iturralde M., Piniero A., Larad L., Alava M.A., Naval J., Anel A. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol. 167:(12):2001;6736-6744.
16. Serrao K.L., Fortenberry J.D., Owens M.L., Harris F.L., Brown L.A. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol Lung Cell Mol Physiol. 280:(2):2001;298-305.
17. Murayama T., Koizumi T., Das H., Dobayashi Y., Kajimoto K., Sugimoto T., Imoto S., Nishimura R., Nakagawa T. Soluble Fas ligand in natural killer cell lymphoma. Am J Hematol. 62:(4):1999;253-255.
18. Kern P., Dietrich M., Hemmer C., Wellinghausen N. Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria. Infect Immun. 68:(5):2000;3061-3063.
19. Sohn M.H., Kin J.-W., Kin W.K., Jang G.C., Kim E.-E. Staphylococcal enterotoxin B upregulates Fas-mediated apoptosis of peripheral blood mononuclear cells in childhood atopic dermatitis. Scan J Immunol. 57:(1):2003;62-67.
20. Evans D.L., Jaso-Friedmann L. Nonspecific cytotoxic cells as effectors of immunity in fish. Ann Rev Fish Dis. 2:1992;109-121.
21. Shen L., Stuge T.B., Zhou H., Khayat M., Barker K.S., Quiniou S.M., Wilson M., Bengten E., Chinchar V.G., Clem L.W., Miller N.W. Channel catfish cytotoxic cells: a mini-review. Dev Comp Immunol. 26:(2):2002;141-149.
22. Jaso-Friedmann L. III, Leary J.H., Evans D.L. Role of nonspecific cytotoxic cells in the induction of programmed cell death of pathogenic protozoans: participation of the Fas ligand-Fas receptor system. Exp Para. 96:(2):2000;75-88.
23. Evans D.L., Taylor S.L. III, Leary J.H., Bishop G.R., Jaso-Friedmann L. In vivo activation of nonspecific cytotoxic cells by Streptococcus iniae and amplification with apoptosis regulatory factors (s). Fish and Shellfish Immunol. 10:(5):2000;419-434.
24. Jaso-Friedmann L., Ruiz J., Bishop G.R., Evans D.L. Regulation of innate immunity in tilapia: activation of nonspecific cytotoxic cells by cytokine-like factors. Dev Comp Immunol. 24:(1):2000;25-36.
25. Bishop G.R., Jaso-Friedmann L., Evans D.L. Activation induced programmed cell death of nonspecific cytotoxic cells and inhibition by apoptosis regulatory factors. Cell Immunol. 199:(2):2000;126-137.
26. Evans D.L., Leary J.H., Jaso-Friedmann L. Nonspecific cytotoxic cells and innate immunity: regulation by programmed cell death. Dev Comp Immunol. 25:(8-9):2001;791-805.
27. Bishop G.R., Taylor S., Jaso-Friedmann L., Evans D.L. Mechanisms of nonspecific cytotoxic cell regulation of apoptosis: cytokine-like activity of soluble Fas Ligand. Fish and Shellfish Immunol. 13:(1):2002;47-67.
28. Oumouna M., Jaso-Friedmann L., Evans D.L. Activation of nonspecific cytotoxic cells (NCC) with synthetic oligodeoxynucleotides and bacterial genomic DNA: binding, specificity and identification of unique immunostimulatory motifs. Dev Comp Immunol. 26:(3):2002;257-269.
29. Ballas Z.K., Krieg A.M., Warren T., Rasmussen W., Davis H.L., Waldschmidt M., Weiner G.J. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol. 167:(9):2001;4878- 4886.
30. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol. 157:(5):1996;1840-1845.
31. Kaur H., Jaso-Friedmann L., Evans D.L. Identification of a scavenger receptor homologue on nonspeicific cytotoxic cells and evidence for binding to oligodeoxyguanosine. Fish Shellfish Immunol. 15:(3):2003;169-181.
32. Kaur H, Jaso-Friedmann L, Evans DL. Single base oligodeoxyguanosine binding proteins on nonspecific cytotoxic cells: identification of a new class of pattern recognition receptors; submitted for publication.
33. Evans D.L., Smith E.E., Jaso-Friedmann L., St John A., Koren H.S., Harris D.T. Identification of a putative antigen receptor on fish nonspecific cytotoxic cells with monoclonal antibodies. J Immunol. 141:(1):1988;324-332.
34. Arase H., Arase N., Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med. 181:(3):1995;1235-1238.
35. Tsutsui H., Nakanishi K., Natsui K., Higashino K., Okamura H., Miyazawa Y., Kaneda K. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity or murine natural killer cell clones. J Immunol. 157:(9):1996;3967-3973.
36. Lee R.K., Spielman J., Zhao D.Y., Olsen K.J., Podack E.R. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol. 157:(5):1996;1919-1925.
37. Oshimi Y., Oda S., Honda Y., Natata S., Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol. 157:(7):1996;2909-2915.
38. Eischen C.M., Schilling J.D., Lynch D.H., Drammer P.H., Leibson P.J. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol. 156:(8):1996;2693-2699.
39. Liles W.C. Apoptosis - role in infection and inflammation. Curr Opin Infect Dis. 10:1997;165-170.
40. Tanaka M., Suda T., Takahasi T., Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:(6):1995;1129-1135.
41. Kiener P.A., Davis P.M., Rankin B.M., Klebanoff S.J., Ledbetter J.A., Starling G.C., Liles W.C. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J Immunol. 159:(4):1997;1594-1598.
42. Liles W.C., Kiener P.A., Ledbetter J.A., Aruffo A., Klebanoff S.J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med. 184:(2):1996;429-440.
43. Brown S.B., Savill J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J Immunol. 162:(1):1999;480-485.
44. Seino K., Iwabuchi K., Kayagaki N., Miyata R., Nagaoka I., Matsuzawa A., Fukao K., Yagita H., Okumura K. Chemotactic activity of soluble Fas ligand against phagocytes. J Immunol. 161:(9):1998;4484-4488.
45. Seino K., Kayagaki N., Okumura K., Yagita H. Antitumor effect of locally produced CD95 ligand. Nat Med. 3:(2):1997;165-170.
46. Alderson M.R., Armitage R.J., Maraskovsky E., Tough T.W., Roux E., Schooley K., Ramsdell F., Lynch D.H. Fas transduces activation signals in normal human T lymphocytes. J Exp Med. 178:(6):1993;2231-2235.
47. Rathmell J.C., Townsend S.E., Xu J.C., Flavell R.A., Goodnow C.C. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell. 87:(2):1996;319-329.